Rare Disease Treatments
Pharmaceutical and biotech companies developing orphan drugs and therapies for rare diseases affecting small patient populations
Symbols
LLYLilly(Eli) & CoMarket Cap: $1.1T
ABBVAbbvie IncMarket Cap: $438.3B
NOVNNovartis AGMarket Cap: $294B
NVONovo NordiskMarket Cap: $220.9B
AMGNAMGEN Inc.Market Cap: $196.1B
VRTXVertex Pharmaceuticals, Inc.Market Cap: $123.2B
BRMBristol-Myers Squibb Co.Market Cap: $117.6B
BMYBristol-Myers Squibb Co.Market Cap: $117.6B
REGNRegeneron Pharmaceuticals, Inc.Market Cap: $69.7B
ARGXArgen X SEMarket Cap: $54.3B
SNYSanofiMarket Cap: $53B
ALNYAlnylam Pharmaceuticals IncMarket Cap: $39.9B
RDHLRedhill Biopharma Ltd.Market Cap: $35.4B
EDGGold Fields LtdMarket Cap: $30.6B
BIIBBiogen IncMarket Cap: $29.4B
TAKTakeda Pharmaceutical CoMarket Cap: $28.5B
MRNAModerna IncMarket Cap: $27.1B
ROIVRoivant Sciences LtdMarket Cap: $25.9B
INSMInsmed IncMarket Cap: $25.1B
INCYIncyte Corp.Market Cap: $23.3B